Online citations, reference lists, and bibliographies.
← Back to Search

HSA Coated MnO Nanoparticles With Prominent MRI Contrast For Tumor Imaging.

J. Huang, J. Xie, K. Chen, Lihong Bu, S. Lee, Z. Cheng, X. Li, X. Chen
Published 2010 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We report in this Communication a facile, two-step surface modification strategy to achieve manganese oxide nanoparticles with prominent MRI T1 contrast. In a U87MG glioblastoma xenograft model, we confirmed that the particles can accumulate efficiently in tumor area to induce effective T1 signal alteration.
This paper references
10.1056/NEJMOA022749
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
10.1016/j.biomaterials.2010.01.010
PET/NIRF/MRI triple functional iron oxide nanoparticles.
J. Xie (2010)
10.1263/JBB.100.1
Medical application of functionalized magnetic nanoparticles.
A. Ito (2005)
10.1021/JA0422155
Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging.
Y. Jun (2005)
10.1517/14656566.7.8.1041
Albumin-bound paclitaxel: a next-generation taxane
W. Gradishar (2006)
10.1021/ar700121f
Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences.
Y. Jun (2008)
10.2967/jnumed.108.051243
PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles
Ha-young Lee (2008)
10.1039/c000536c
Near infrared-fluorescent and magnetic resonance imaging molecular probe with high T1 relaxivity for in vivo multimodal imaging.
Kevin Guo (2010)
Angewandte Chemie-International Edition
H. B. Na (2007)
10.1002/ANIE.200604775
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Hyon Bin Na (2007)
10.1021/ja802003h
Ultrasmall c(RGDyK)-coated Fe3O4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells.
Jin Xie (2008)
H B Na
10.1038/NMAT1251
Ultra-large-scale syntheses of monodisperse nanocrystals
J. Park (2004)
10.2174/092986709787846604
Iron oxide nanoparticle platform for biomedical applications.
J. Xie (2009)
10.1002/ADMA.200700763
Controlled Etching of Carbon Nanotubes by Iron‐Catalyzed Steam Gasification
W. Xia (2007)
10.2967/jnumed.107.039859
64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor αvβ3 Integrin Expression
Z. B. Li (2007)
10.1016/j.jconrel.2008.05.010
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.
F. Kratz (2008)
10.1039/b917195a
Human serum albumin coated iron oxide nanoparticles for efficient cell labeling.
Jin Y. Xie (2010)
10.1016/j.biomaterials.2009.08.045
Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting.
K. Chen (2009)
10.1038/nm1467
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
Jaehyun Lee (2007)
10.1002/anie.200802323
Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
Jongmin Shin (2009)



This paper is referenced by
10.4155/TDE.10.106
Research Spotlight: Moving theranostics from bench to bedside in an interdisciplinary research team
Magdalena Swierczewska (2011)
10.1021/am505223t
Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.
N. Chen (2014)
10.7150/thno.19365
Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery
F. An (2017)
Intestinal Stem Cells in GI Physiology and Disease Mesenchymal stromal cell therapy in liver disease : opportunities and lessons to be learnt ?
A. Owen (2015)
10.1371/journal.pone.0200053
Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin
Shreya Dubey (2018)
10.1016/J.TET.2011.07.076
Manganese-based MRI contrast agents: past, present and future.
D. Pan (2011)
10.1186/1471-2342-13-17
Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma
N. R. S. Varma (2013)
10.7150/thno.23789
Surface impact on nanoparticle-based magnetic resonance imaging contrast agents
W. Zhang (2018)
10.1002/anie.201806853
Multimodality Imaging Agents with PET as the Fundamental Pillar.
D. Ni (2019)
Cellular interactions underpinning the immunomodulatory action of mesenchymal stromal cells in models of liver transplant injury
Andrew Owen (2018)
10.1016/J.MATTOD.2015.11.006
Chemical design of nanoprobes for T1-weighted magnetic resonance imaging
Yung-Kang Peng (2016)
10.3390/molecules22122208
In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles
Yonghua Zhan (2017)
10.1039/C6TB01787H
Difunctional fluorescent HSA modified CoFe2O4 magnetic nanoparticles for cell imaging.
Qianfang Yao (2016)
10.1039/C5RA24775F
Phase transfer preparation of ultrasmall MnS nanocrystals with a high performance MRI contrast agent
Jing Meng (2016)
10.1039/c5nr00451a
Composition-property relationships in multifunctional hollow mesoporous carbon nanosystems for PH-responsive magnetic resonance imaging and on-demand drug release.
S. Zhang (2015)
10.1016/j.colsurfb.2017.12.034
Polyglycerol grafting and RGD peptide conjugation on MnO nanoclusters for enhanced colloidal stability, selective cellular uptake and cytotoxicity.
X. Yang (2018)
10.1039/c0dt00689k
Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment.
Thomas D. Schladt (2011)
10.1063/5.0011230
In vitro and ex vivo relaxometric properties of ethylene glycol coated gadolinium oxide nanoparticles for potential use as contrast agents in magnetic resonance imaging
Anamika Chaturvedi (2020)
10.1002/adtp.201800078
Multifunctional Mesoporous Silica Nanoprobes: Material Chemistry–Based Fabrication and Bio‐Imaging Functionality
Luodan Yu (2018)
10.1039/c3nr04832b
Formation of octapod MnO nanoparticles with enhanced magnetic properties through kinetically-controlled thermal decomposition of polynuclear manganese complexes.
F. Douglas (2014)
10.4103/2152-7806.151334
Bionanotechnology and the Future of Glioma
P. Chiarelli (2015)
10.1016/j.addr.2016.08.001
Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics☆
S. Goel (2017)
10.1002/PPSC.201500189
Human-Serum-Albumin-Coated Prussian Blue Nanoparticles as pH-/Thermotriggered Drug-Delivery Vehicles for Cancer Thermochemotherapy
Zhenglin Li (2016)
10.1117/12.2289273
HSA/PSS coated gold nanorods as thermo-triggered drug delivery vehicles for combined cancer photothermal therapy and chemotherapy
Ting-Yu Tu (2018)
10.1021/ACSOMEGA.8B00923
Bimetallic Zeolitic Imidazolate Framework as an Intrinsic Two-Photon Fluorescence and pH-Responsive MR Imaging Agent
Gaozheng Zhao (2018)
10.1007/s11356-017-8531-6
The effect of iron nanoparticles on performance of cognitive tasks in rats
E. Sheida (2017)
sPIONs for bimodal targeted imaging of pancreatic cancer cells
Xiaohui Wang (2014)
10.1152/ajpgi.00036.2015
Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?
Andrew Owen (2015)
10.1039/c4nr04853a
Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.
S. Dixit (2015)
10.1016/J.CARBON.2016.09.030
Biocompatible caramelized carbonaceous nanospheres supported paramagnetic ultrathin manganese oxide nanosheets via self-sacrificing reduction as a MRI contrast agent for liver imaging
W. Guo (2016)
10.5772/22873
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Xiang-hong Peng (2008)
10.2174/138920021131400109
Pharmacokinetics and applications of magnetic nanoparticles.
Runyi Mao (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar